60 Degrees Pharmaceuticals Debt to Equity

The latest debt-to-equity ratio for SXTP is 0.0. That is below the sector sector average of 0.2. Investors often review this figure alongside 60 Degrees Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SXTP currently prints 0.0 for debt-to-equity ratio, while the sector average sits near 0.2. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at 60 Degrees Pharmaceuticals's growth, margins, and balance sheet.

A debt-to-equity ratio of 0.0 for 60 Degrees Pharmaceuticals is not 'good' or 'bad' on its own. Compare it with the peer average (0.2) and with SXTP's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting SXTP's debt-to-equity ratio (0.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.